The effects of chronic exposure to JP-4 gas were evaluated in mice, rats, and dogs. Beagle dogs, F344-rats, and C57BL/6-mice were exposed to 500 and 1,000mg/m3 JP-4 for 90 days for 23 hours per day, which simulated worst case conditions for people. The dogs and one third of rodents were euthanized following exposure, and remaining rodents were held for 19 or 21 months to determine tumorigenesis. No clinical signs of toxic stress or mortality occurred during the 90 day exposure period. Gross examination of dogs found roundworm infections and mild inflammatory changes in lungs that were not JP-4 related. Histopathology of rats found hyaline droplet formation in kidneys of 100% of rats exposed to 1,000mg/m3 JP-4 and 96% of rats exposed to 500mg/m3 JP-4 compared with only 7% of control rats. In mice, hepatocellular fatty changes occurred in 89% of the low JP-4 group, 90% of the high JP-4 group, and 4% of controls. Kidney ultrastructure of JP-4 male rats showed hyaline, crystalloid intracytoplasmic inclusions in the proximal tubules, and the severity was greater in the high dose group. At 19 and 21 months, rats showed no hyaline droplets were seen, but instead, an increased incidence of medullary mineralization and hyperplasia of pelvic urothelium. Mice showed no changes at 19 and 21 months that differed from controls. The authors conclude that the most significant finding is increased renal disease in male rats.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.